drugset / Trial / NCT03016650

Opioid-sparing Effect of Intravenous Ibuprofen

NCT03016650 ↗

Phase 4 Unknown 80 enrolled Muharrem Ucar
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators aimed to evaluate tramadol-sparing effect of intravenous (IV) ibuprofen in patients undergoing percutaneous nephrolithotomy (PCNL).

Timeline

Start
2017-01
Primary completion
2017-04
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 1 g Intravenous
Comparator Ibuprofen Small molecule 800 mg Intravenous

Indications